BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24748557)

  • 1. Assessing quality of life in patients with prostate cancer: a systematic and standardized comparison of available instruments.
    Schmidt S; Garin O; Pardo Y; Valderas JM; Alonso J; Rebollo P; Rajmil L; Garcia-Forero C; Ferrer M;
    Qual Life Res; 2014 Oct; 23(8):2169-81. PubMed ID: 24748557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing health-related quality of life in patients with breast cancer: a systematic and standardized comparison of available instruments using the EMPRO tool.
    Maratia S; Cedillo S; Rejas J
    Qual Life Res; 2016 Oct; 25(10):2467-2480. PubMed ID: 27048496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing oral health-related quality of life in children and adolescents: a systematic review and standardized comparison of available instruments.
    Zaror C; Pardo Y; Espinoza-Espinoza G; Pont À; Muñoz-Millán P; Martínez-Zapata MJ; Vilagut G; Forero CG; Garin O; Alonso J; Ferrer M
    Clin Oral Investig; 2019 Jan; 23(1):65-79. PubMed ID: 29569021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability and validity of the PORPUS, a combined psychometric and utility-based quality-of-life instrument for prostate cancer.
    Ritvo P; Irvine J; Naglie G; Tomlinson G; Bezjak A; Matthew A; Trachtenberg J; Krahn M
    J Clin Epidemiol; 2005 May; 58(5):466-74. PubMed ID: 15845333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring health-related quality of life in men with prostate cancer: A systematic review of the most used questionnaires and their validity.
    Hamoen EH; De Rooij M; Witjes JA; Barentsz JO; Rovers MM
    Urol Oncol; 2015 Feb; 33(2):69.e19-28. PubMed ID: 24433753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating conceptual model measurement and psychometric properties of Oral health-related quality of life instruments available for older adults: a systematic review.
    Deana NF; Pardo Y; Ferrer M; Espinoza-Espinoza G; Garin O; Muñoz-Millán P; Atala-Acevedo C; Pont À; Cancino M; Zaror C
    Health Qual Life Outcomes; 2024 Jan; 22(1):5. PubMed ID: 38218930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping the Patient-Oriented Prostate Utility Scale From the Expanded Prostate Cancer Index Composite and the Short-Form Health Surveys.
    Zamora V; Garin O; Pardo Y; Pont À; Gutiérrez C; Cabrera P; Gómez-Veiga F; Pijoan JI; Litwin MS; Ferrer M;
    Value Health; 2021 Nov; 24(11):1676-1685. PubMed ID: 34711369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of shoulder-specific patient-reported outcome measures: a systematic and standardized comparison of available evidence.
    Schmidt S; Ferrer M; González M; González N; Valderas JM; Alonso J; Escobar A; Vrotsou K;
    J Shoulder Elbow Surg; 2014 Mar; 23(3):434-44. PubMed ID: 24406123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.
    Wei JT; Dunn RL; Litwin MS; Sandler HM; Sanda MG
    Urology; 2000 Dec; 56(6):899-905. PubMed ID: 11113727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting utility scores for prostate cancer: mapping the Prostate Cancer Index to the Patient-Oriented Prostate Utility Scale (PORPUS).
    Bremner KE; Mitsakakis N; Wilson L; Krahn MD
    Prostate Cancer Prostatic Dis; 2014 Mar; 17(1):47-56. PubMed ID: 24126796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring prostate-specific quality of life in prostate cancer patients scheduled for radiotherapy or radical prostatectomy and reference men in Germany and Canada using the Patient Oriented Prostate Utility Scale-Psychometric (PORPUS-P).
    Waldmann A; Rohde V; Bremner K; Krahn M; Kuechler T; Katalinic A
    BMC Cancer; 2009 Aug; 9():295. PubMed ID: 19698163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptation and validation of the Spanish version of the Patient-Oriented Prostate Utility Scale (PORPUS).
    Avila M; Pardo Y; Castells M; Ferrer F; Boladeras A; Pera J; Prada PJ; Guix B; de Paula B; Hernandez H; Pont A; Alonso J; Garin O; Bremner K; Krahn M; Ferrer M;
    Qual Life Res; 2014 Nov; 23(9):2481-7. PubMed ID: 24789667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responsiveness of disease-specific and generic utility instruments in prostate cancer patients.
    Krahn M; Bremner KE; Tomlinson G; Ritvo P; Irvine J; Naglie G
    Qual Life Res; 2007 Apr; 16(3):509-22. PubMed ID: 17091359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in men with localized prostate cancer treated with radiotherapy: validation of an abbreviated version of the Expanded Prostate Cancer Index Composite for Clinical Practice in Spain.
    Zapatero A; Maldonado Pijoan X; Gómez-Caamaño A; Pardo Masferrer J; Macías Hernández V; Hervás Morón A; Muñoz García JL; Palacios Eito A; Anguita-Alonso P; González-Junco C; López Torrecilla J
    Health Qual Life Outcomes; 2021 Sep; 19(1):223. PubMed ID: 34563208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-reported outcome (PRO) questionnaires for men who have radical surgery for prostate cancer: a conceptual review of existing instruments.
    Protopapa E; van der Meulen J; Moore CM; Smith SC
    BJU Int; 2017 Oct; 120(4):468-481. PubMed ID: 28437031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A reference set of health utilities for long-term survivors of prostate cancer: population-based data from Ontario, Canada.
    Krahn MD; Bremner KE; Alibhai SM; Ni A; Tomlinson G; Laporte A; Naglie G
    Qual Life Res; 2013 Dec; 22(10):2951-62. PubMed ID: 23564620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constant-Murley Score: systematic review and standardized evaluation in different shoulder pathologies.
    Vrotsou K; Ávila M; Machón M; Mateo-Abad M; Pardo Y; Garin O; Zaror C; González N; Escobar A; Cuéllar R
    Qual Life Res; 2018 Sep; 27(9):2217-2226. PubMed ID: 29748823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychometric Assessment of the Chinese Version of the Abbreviated Expanded Prostate Cancer Index Composite (EPIC-26) and the Clinical Practice Version (EPIC-CP) in Chinese Men With Prostate Cancer.
    Lam WWT; Tse MA; Ng CNL; Chung EKM; Fielding R
    J Pain Symptom Manage; 2017 Jun; 53(6):1085-1090. PubMed ID: 28438583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure.
    Litwin MS; Hays RD; Fink A; Ganz PA; Leake B; Brook RH
    Med Care; 1998 Jul; 36(7):1002-12. PubMed ID: 9674618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-cultural adaptation and validation of the French version of the Expanded Prostate cancer Index Composite questionnaire for health-related quality of life in prostate cancer patients.
    Anota A; Mariet AS; Maingon P; Joly F; Bosset JF; Guizard AV; Bittard H; Velten M; Mercier M
    Health Qual Life Outcomes; 2016 Dec; 14(1):168. PubMed ID: 27923377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.